Agenovir
Latest round
- Series A
Last raised
- May 2016
Total raised
- $11M
Investors
- 3
About Agenovir
Agenovir specializes in the research and development of antiviral therapies aimed at addressing pressing viral health challenges. The company is headquartered in San Francisco, US.Agenovir is developing a suite of antiviral therapies employing cutting-edge genomic technologies. Their primary focus is on crafting effective drugs for viral diseases, addressing critical health needs across various demographics. The company aims to launch new products targeting specific viral infections in the next 18-24 months. Furthermore, Agenovir is looking to expand its market reach into Europe and Asia, focusing on regions that have a high prevalence of viral diseases. As they progress, they intend to establish collaborations with healthcare organizations to facilitate product deployment and enhance market penetration.
Who invested in Agenovir
3 investors across 1 round
See all investors in Agenovir
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 17, 2016
Amount
$11M
Investors
Questions about Agenovir
Who invested in Agenovir?
Agenovir has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Agenovir raised?
Agenovir has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Agenovir last raise money?
Agenovir's most recent round on record is a Series A, in May 2016.
What does Agenovir do?
Agenovir specializes in the research and development of antiviral therapies aimed at addressing pressing viral health challenges.
Where is Agenovir headquartered?
Agenovir is headquartered in San Francisco, US.
Which VCs invest in companies like Agenovir?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Kleiner Perkins and Lightspeed Venture Partners back healthcare companies at Agenovir's stage. Their profiles are linked below.
VCs backing healthcare startups at Series A
Raising like Agenovir? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.